ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ)
$8.69 -0.26 (-2.905%)
Analysed ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ) News Sources
Anteris treats first US patients in DurAVR pivotal trial
07-05-2026
proactiveinvestors.com
Anteris secures US Medicare coverage for PARADIGM Trial as DurAVR study advances
07-05-2026
proactiveinvestors.com
Anteris Announces Results for the First Quarter of 2026
12-05-2026
yahoo.com
Anteris advances PARADIGM trial as Q1 cash burn reflects commercialisation push
12-05-2026
proactiveinvestors.com
Anteris adds Susan Knight, Stephen Denaro to board as company advances heart valve strategy
13-05-2026
proactiveinvestors.com
Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors
13-05-2026
yahoo.com
Here's Why We're Not Too Worried About Anteris Technologies Global's (ASX:AVR) Cash Burn Situation
13-05-2026
yahoo.com
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
08-06-2026
yahoo.com
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial
08-06-2026
proactiveinvestors.com
TAVR Changed Valve Replacement; Anteris Says Longer-Living Patients Expose the Next Challenge
15-06-2026
yahoo.com
What is the current price of ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ)?
The current price of ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ) is $8.69.
ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ) absolute price change since previous trading day?
The absolute price change of ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ) since the previous trading day is $-0.26.
ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ) percentage price change since previous trading day?
The percentage price change of ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ) since the previous trading day is -2.905%.
What is the most recent average sentiment score for ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ)?
The most recent average sentiment score for ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ)?
The most recent sentiment for ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ) is .
SEC-8K** Filing Available For ANTERIS TECHNOLOGIES GLOBAL (AVR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.